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plasma HCY and B-type natriuretic peptide (BNP) levels at the next morning after
admission of the patients of DCM and paroxysmal supraventricular tachycardia.
Results: Plasma HCY level in dilated cardiomyopathy group was signiﬁcantly higher
than in control group. Correlation analysis showed that plasma HCY level is positively
correlated with heart function and plasma BNP level, and is signiﬁcantly correlated
with left ventricular diastolic diameter and end-systolic diameter, and is negatively
correlated with ejection fraction.
Conclusions: Plasma HCY level was associated with the severity degree of heart
failure and was positively related to plasma BNP level. HCY may direct or indirect
affect the myocardium. Therefore, HCY may be a potential etiology of the occurrence
and development of chronic heart failure, which provides a new idea for the treatment
of chronic heart failure.
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Objectives: Depression is a common psychological disorder in heart failure (HF)
patients with increased risks of mortality and reduced quality of life. The aim of this
study was to identify the inﬂuence of depressive symptoms on plasma levels of sol-
uble ST2 (sST2) and neurohormones [N-terminal pro-brain natriuretic peptide
(NT-pro BNP) and ghrelin] in patients with systolic HF.
Methods: A cohort of 146 HF patients with left ventricular ejection fraction (LVEF)
less than 40% was followed up for 1 year. The primary endpoint was all-cause
mortality and HF-related hospitalization. Psychological status was evaluated by
Hospital Anxiety and Depression Scale (HADS) and Hamilton Depression Scale
(HAMD). Plasma levels of sST2, NT-pro BNP and ghrelin were measured at baseline.
Patients were eligible if they were clinically diagnosed of HF, aged over 18 years, had
a LVEF less than 40% with New York Heart Association functional class II-IV and
treated with standard medications of HF for at least 3 months. Participants who had
myocardial infarction within 1 month, congenital heart disease, peripartum cardio-
myopathy, gastric diseases, malignant, current thyroid diseases, severe cognitive
dysfunction, severe dysfunction of the liver or renal were excluded. We also elimi-
nated patients with history of psychiatric diseases, or patients who were slated for
cardiac transplantation in the next 6 months.
Results: HF patients with depressive symptoms (n¼52, 35.6%) had higher levels of
sST2 (55.3 ng/ml vs. 41.1 ng/ml, P<0.001) and NT-pro BNP (5886 pg/ml vs. 2682
pg/ml, P<0.001), but lower levels of ghrelin (7.0 ng/ml vs. 7.9 ng/ml, P¼0.041),
compared with those without depressive symptoms. Levels of sST2 and NT-pro BNP
were independently associated with depressive symptoms. After 1-year follow-up, 33
patients (22.6%) died and 53 (36.3%) patients achieved the primary endpoint. The
hazard ratio (HR) of all-cause death and HF-related hospitalization was 2.2 [95%
conﬁdence interval (CI) 1.34-3.52, P¼0.002] in patients with depressive symptoms
when adjusted for clinical covariates, including age, gender, BMI, e GFR, LVEF,
NYHA class and NT-pro BNP. Depressive symptoms combined with upper risk
threshold levels (>36.0 ng/ml) of sST2 (HR 3.65, 95% CI 1.66-8.02, P¼0.001) or
NT-pro BNP (HR 2.99, 95% CI 1.24-7.21, P¼0.014) were independently associated
with increased risks of death and HF-related hospitalization. ROC curves showed that
the combination of depression scales (HAMD and depression subscale of HADS) with
sST2 or NT-pro BNP signiﬁcantly improved the prognostic value than sST2 or NT-
pro BNP alone (sST2+HAMD+HADS-D vs. sST2, P¼0.019; NT-pro
BNP+HAMD+HADS-D vs. NT-pro BNP, P¼0.016).
Conclusions: Depressive symptoms were independent risk factors of HF and provided
additional prognostic information to that of sST2 and NT-pro BNP for all-cause
mortality and HF-related hospitalization during 1-year follow-up.
GW25-e1076
Analysis of Relationship between Clinical Features and Heart Failure in 214
acute ST-segment elevation Myocardial Infarction
Yu Yanan, Yang Ping
Jilin Provincial China-Japan union Hospital
Objectives: To analyze clinical data of 214 acute ST-elevation Myocardial Infarction
(STEMI) hospitalized patients in retrospecte, discuss the correlationshiop between
clinical features and heart failure in STEMI hospitalized patients.
Methods: It was retrospectively analyzed that involve 214 STEMI patients treated in
Jilin Provincial China-Japan union Hospital and receiced PCI from January 2013 to
December 2013. The 214 cases were divided into heart failure group (n¼78) and non-
heart failure group (n¼136) based on the Left ventricular ejection fraction. Analysis
two sets of data on a single factor, including hospitalization, medical history, ECG
changes, coronary angiography, laboratory tests, echocardiography related indicators
and therapy situations, then collect related risk factors (P<0.05) into multivariate
Logistic regression analysis to discovery independent risk factors for heart failure in
STEMI patients after PCI.
Results: There are 78 case in heart failure group and 136 case in non-heart failure
group. Clinical material characteristics : 48 case old patients in heart failure groupC188 JACC Vol 64/16/Suppl C j October 16–1while 56 case old patients in non-heart failure group, difference of age was statis-
tically signiﬁcant (P¼0.004).The heart rate (84.016.1) and the systolic blood
pressure (144.734.7) of heart failure group is higher than (75.416.4),
(136.425.4) in non-heart failure group. 13 case in heart failure group with Atrial
ﬁbrillation, 8 case in non-heart failure group with Atrial ﬁbrillation, it is tatistically
signiﬁcant. Analysis Coronary arteries between two group, STEMI patients with
multivessel disease has more probability to be heart failure (P¼0.00). Further divided
214 STEMI into Left anterior descending artery disease (126 case) and not Left
anterior descending artery disease (88case), primary artery difference was statistically
signiﬁcant (P<0.05).The analysis of different patency time between two group
conﬁrm that the earlier patency of the artery, the less the possibility of heart failure.
The analysis of laboratory parameters suggest that cTNI (27.1628.89) and BNP
(10221.436269.00) of heart failure patients with were higher than those of non-
heart failure group cTNI (4.759.69), BNP (2018.871752.81), both have signiﬁ-
cant difference (P<0.05). Analyze of treatment strategies of STEMI patients between
two group show that the use of ACEI and trimetazidine was signiﬁcantly higher in
on-heart failure group than in heart failure group. Single- factor statistic ﬁnd the
possible associated risk factors include age, heart rate, systolic blood pressure, Atrial
ﬁbrillation, Coronary arteries, Left anterior descending artery disease, different
patency time, BNP, cTNI, use of ACEI and trimetazidine. Further reaserch about the
possible associated risk factors in more factors Logistic regression analysis showed
that a STEMI patient with Left anterior descending artery diseaseand with higher
cTNI is more likely to be heart failure. And the use of trimetazidine will induce the
possibility
Conclusions: (1) The risk of STEMI patients with heart failure signiﬁcantly
increased with age, heart rate, high systolic blood pressure, Atrial ﬁbrillation, high
BNP, high cTNI, Multivessel disease and Left anterior descending artery disease. (2)
The use of trimetazidine and ACEI will induce the possibility of heart failure in
STEMI patients with conventional treatment after PCI. (3) Left anterior descending
artery diseaseand and higher cTNI were independent danger factor for STEMI
patients heart failure.
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Objectives: Pulmonary abnormalities are found in both chronic heart failure
(CHF) and pulmonary arterial hypertension (PAH). The differences of pulmonary
function in chronic left heart failure and chronic right heart failure are not fully un-
derstood. In the research, we evaluated the pulmonary function at both rest and ex-
ercise by cardiopulmonary exercise testing (CPX) in patients with chronic left heart
failure and right heart failure secondary to PAH and analyzed the differences in two
groups.
Methods: We successively evaluated patients with chronic left heart failure and
right heart failure secondary to PAH between October 2010 and December 2012.
All patients with right heart failure underwent right heart catheterization 3 days after
CPX to determine the pulmonary arterial pressure, cardiac index and pulmonary
capillary wedge pressure. All patients underwent echocardiography on the same
day before CPX, and CPX to determine the pulmonary function at both rest and
exercise.
Results: There were 120 patients involved in the study, including 60 patients with
chronic left heart failure and 60 patients with right heart failure secondary to PAH.
Patients with right heart failure were younger (30.89.5 years vs 45.19.9 years,
P<0.001), had less men (10 vs 53, P<0.001) and smoker (4 vs 37, P<0.001), and had
a lower BMI (22.132.95 kg/m2 vs 24.123.94 kg/m2, P¼0.002). Patients with right
heart failure had a signiﬁcantly lower end-tidal partial pressure of CO2 (33.724.47
mmHg vs 28.784.25 mmHg, P<0.001), higher end-tidal partial pressure of O2
(110.687.48 mmHg vs 115.806.65 mmHg, P<0.001) and minute ventilation/CO2
production (37.966.50 L/min/L/min vs 43.456.79 L/min/L/min, P<0.001) at rest.
Patients with right heart failure had a lower peak end-tidal partial pressure of CO2
(33.426.04 mmHg vs 24.325.30 mmHg, P<0.001), and a higher peak dead space
volume/ tidal volume ratio (27.184.02% vs 28.834.04%, P¼0.027), peak end-tidal
partial pressure of O2 (117.176.10 mmHg vs 124.435.61 mmHg, P<0.001), peak
minute ventilation/CO2 production (36.137.97 L/min/L/min vs 48.5011.95
L/min/L/min, P<0.001), and minute ventilation/CO2 production slope (32.747.52 vs
45.7016.18, P¼0.001) during exercise. Patients with right heart failure had lower
changes in end-tidal partial pressure of CO2 (-0.6114.16% vs -15.6112.91%,
P<0.001) and minute ventilation/CO2 production (4.5516.28% vs -11.4618.68%,
P<0.001) from rest to exercise.
Conclusions: Patients with right heart failure had worse pulmonary function at rest
and exercise. The differences in pulmonary function at rest were due to patients with
right heart failure had hyperventilation in some alveolar. The pulmonary function
differences during exercise were due to hyperventilation in some alveolar, severe
ventilation/perfusion mismatching, severe gas exchange abnormality and worse car-
diopulmonary adaptation to exercise.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
